What’s new at the Rosalind & Morris Goodman Cancer Institute?

The Rosalind and Morris Goodman Cancer Institute (GCI) is dedicated to shaping the future of cancer research by recruiting exceptional graduate students from across Canada and beyond. Our Annual Graduate Recruitment Event is a key part of this mission, connecting aspiring researchers with the institute’s vibrant academic community.

In recognition of Pancreatic Cancer Awareness Month, the Rosalind and Morris Goodman Cancer Institute (GCI) is highlighting the groundbreaking research of Dr. George Zogopoulos.

A team of passionate undergraduate researchers has been awarded Centre de Recherche en Biologie Structurale (CRBS) Blue Sky Seed Funding to pursue an exciting CRISPR-based cancer treatment. This undergraduate led initiative was developed at McGill and won the Grand Prize at the 2023 iGEM Grand Jamboree – the top world-wide student competition in synthetic biology.

November is Lung Cancer Awareness Month, a time when advocates spotlight the urgent need to invest in lung cancer research. At the Rosalind and Morris Goodman Cancer Institute (GCI), significant strides in lung cancer research have been made, thanks to the dedication of our researchers and the steadfast support of our community.

From October 17-18th, the Rosalind and Morris Goodman Cancer Institute (GCI) hosted the 2024 Gairdner Symposium on Diet, Bodyweight and Cancer Risk. With well over 200 participants, this event was one of the largest conferences organized and hosted by the GCI since its inception.

The Rosalind and Morris Goodman Cancer Institute (GCI), including members of the Departments of Biochemistry and Physiology, recently came together to celebrate the well-deserved tenure appointments of Professors Lawrence Kazak, Daniela Quail, and Logan Walsh.

October is the awareness month for breast cancer, a disease which has been a major research focus at the Rosalind and Morris Goodman Cancer Institute (GCI) since its inception. World-leading scientists at the GCI have led new discoveries in breast cancer, developed breast cancer models used by the global research community, and pioneered an understanding of the importance of the breast tumor environment on cancer initiation and progression.

Members of the Rosalind and Morris Goodman Cancer Institute (GCI) joined our community in showing support for the Terry Fox Foundation at the 2024 Montreal Terry Fox Run.

The Rosalind and Morris Goodman Cancer Institute (GCI)’s distinguished alumna, Sylvia Andrzejewski, has made significant strides in the field of cancer research and drug development. From lab benches to leadership in biotech, we had the pleasure of catching up with Sylvia to learn more about her career in industry.